PoddsändningarUtbildningHematologic Oncology Update

Hematologic Oncology Update

Dr. Neil Love
Hematologic Oncology Update
Senaste avsnittet

132 avsnitt

  • Hematologic Oncology Update

    Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Presentations from the 2025 ASH Annual Meeting

    2026-03-11 | 47 min.
    Prof Constantine Tam from Monash University in Melbourne, Australia, reviews recent datasets and discusses their implications for current and future management of chronic lymphocytic leukemia.
    CME information and select publications here.
  • Hematologic Oncology Update

    Immune Thrombocytopenia — Microlearning Activity 2 with Dr Hanny Al-Samkari: ASH 2025 Review

    2026-03-09 | 19 min.
    Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston discusses recent developments from the ASH 2025 Annual Meeting involving the use of Bruton tyrosine kinase inhibitors and BAFF-R antagonists in the treatment of immune thrombocytopenia.
    CME information and select publications here.
  • Hematologic Oncology Update

    Immune Thrombocytopenia — Microlearning Activity 1 with Dr Hanny Al-Samkari: ASH 2025 Review

    2026-03-04 | 24 min.
    Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston discusses recent developments from the ASH 2025 Annual Meeting involving the use of Bruton tyrosine kinase inhibitors and BAFF-R antagonists in the treatment of immune thrombocytopenia.
    CME information and select publications here.
  • Hematologic Oncology Update

    Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators

    2026-02-18 | 57 min.
    Dr Natalie S Callander from the University of Wisconsin Carbone Cancer Center in Madison and Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the potential role of CELMoDs in the management of multiple myeloma, supporting clinical data and ongoing investigations.
    CME information and select publications here.
  • Hematologic Oncology Update

    Relapsed/Refractory Multiple Myeloma — Microlearning Activity 2 with Dr Sagar Lonial: ASH 2025 Review

    2026-02-13 | 17 min.
    Dr Sagar Lonial from Winship Cancer Institute in Atlanta, Georgia, discusses recent clinical developments with BCMA-targeted therapy and investigational agents for relapsed/refractory multiple myeloma presented at ASH 2025.
    CME information and select publications here.

Fler podcasts i Utbildning

Om Hematologic Oncology Update

Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
Podcast-webbplats

Lyssna på Hematologic Oncology Update, Max Tänt med Max Villman och många andra poddar från världens alla hörn med radio.se-appen

Hämta den kostnadsfria radio.se-appen

  • Bokmärk stationer och podcasts
  • Strömma via Wi-Fi eller Bluetooth
  • Stödjer Carplay & Android Auto
  • Många andra appfunktioner

Hematologic Oncology Update: Poddsändningar i Familj

Sociala nätverk
v8.7.2 | © 2007-2026 radio.de GmbH
Generated: 3/12/2026 - 5:28:30 AM